Integra Lifesciences Holdings (IART) Non-Current Assets (2009 - 2026)

Integra Lifesciences Holdings has disclosed Non-Current Assets across 18 years of filings, most recently posting $2.4 billion for Q2 2026.

• In Q2 2026, Non-Current Assets fell 6.06% year-over-year to $2.4 billion; the TTM figure through Jun 2026 stood at $9.7 billion (down 14.65% YoY), while the FY2025 annual figure was $2.4 billion, down 17.37% from the prior year.
• Non-Current Assets came in at $2.4 billion for Q2 2026 at Integra Lifesciences Holdings, down from $2.4 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $3.0 billion in Q3 2024 to a low of $2.4 billion in Q2 2026.
• Average Non-Current Assets over 5 years is $2.7 billion, with a median of $2.7 billion recorded in 2023.
• Year-over-year, Non-Current Assets increased 10.63% in 2025 and dropped 18.33% in 2026.
• Over 5 years, Non-Current Assets stood at $2.7 billion in 2022, then slipped by 0.16% to $2.7 billion in 2023, then advanced by 8.51% to $3.0 billion in 2024, then dropped by 17.37% to $2.4 billion in 2025, then decreased by 2.88% to $2.4 billion in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $2.4 billion in Q2 2026, $2.4 billion in Q1 2026, and $2.4 billion in Q4 2025.